• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PSTX

PSTX

Poseida Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD9.50

+0.00 (+0.00%)

Company Profile

CEO

Mark J. Gergen

IPO Date

2020-07-10

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$9.58

Prev. Close

$9.50

Day Low

$9.50

Day High

$9.58

52W Low

$1.87

52W High

$9.67

Market Cap

$0.93B

Volume

21.34M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

9

Avg Positive

41.6%

Avg Negative

1.2%

Avg Neutral

57.3%

News Feed

Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders

PRNewsWire·6/2/2021·↑ positive

Poseida Therapeutics Reports Program Updates and Financial Results for the First Quarter 2021

PRNewsWire·5/11/2021·↑ positive

Poseida Therapeutics to Present at BofA Securities 2021 Virtual Health Care Conference

PRNewsWire·5/5/2021
·↑ positive

Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting

PRNewsWire·4/27/2021·↑ positive

Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences

PRNewsWire·4/8/2021·↑ positive

Poseida: Early Stage CAR-T And Gene Therapy Developer

Seeking Alpha·3/18/2021·↑ positive

Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020

PRNewsWire·3/11/2021·↑ positive

Why Poseida Therapeutics Stock Is Popping Today

The Motley Fool·2/24/2021·↑ positive

Poseida Therapeutics Provides Update on Phase 1 Trial of P-BCMA-101 at the 2020 American Society of Hematology Annual Meeting

PRNewsWire·12/5/2020·↑ positive